[Clinical use of ethinyl estradiol in combination with cyproterone acetate. Study based on 50 cases (author's transl)].
D000152:Acne Vulgaris; D000505:Alopecia; D000728:Androgens; D001695:Biology; D003267:Contraception; D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003276:Contraceptives, Oral; D003278:Contraceptives, Oral, Hormonal; D017373:Cyproterone Acetate; D003872:Dermatitis; D004194:Disease; D004703:Endocrine System; D004997:Ethinyl Estradiol; D005193:Family Planning Services; D006201:Hair Diseases; D006628:Hirsutism; D006727:Hormone Antagonists; D006728:Hormones; D010827:Physiology; D012102:Reproductive Control Agents; D012106:Research; D012816:Signs and Symptoms; D012867:Skin
D000728:Androgens; D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003276:Contraceptives, Oral; D003278:Contraceptives, Oral, Hormonal; D006727:Hormone Antagonists; D006728:Hormones; D012102:Reproductive Control Agents; D004997:Ethinyl Estradiol; D017373:Cyproterone Acetate
Acne; Alopecia; Androgens; Biology; Clinical Research; Contraception; Contraceptive Agents; Contraceptive Agents, Estrogen; Contraceptive Agents, Female; Contraceptive Methods--indications; Contraceptive Methods--side effects; Cyproterone Acetate; Dermatitis; Dermatological Effects; Diseases; Endocrine System; Ethinyl Estradiol; Family Planning; Hair Diseases; Hirsutism; Hormone Antagonists; Hormones; Oral Contraceptives--indications; Oral Contraceptives--side effects; Physiology; Reproductive Control Agents; Research Methodology; Signs And Symptoms
Utilisation clinique d'une association ethinyl-estradiol acetate de cyproterone. A propos de 50 cas.